Henry Schein and Vets First Choice Announce New Name of the Planned New Company: Covetrus
As co-founder and chair of Vets First choice, I share the news that Henry Schein, Inc. (Nasdaq: HSIC) and Vets First Choice today announced the name Covetrus for the new public company that will result from the planned spin-off of the Henry Schein Animal Health business and the subsequent merger with Vets First Choice. The transaction is expected to be completed in the first quarter of 2019.
The new company will be a global, technology-enabled animal health business supporting the companion, equine and large-animal veterinary markets. Covetrus will combine leading practice management software, prescription management, multi-channel client engagement services, and supply chain infrastructure to promote connectivity between veterinarians and their clients. The company will employ more than 5,000 team members across approximately 25 countries, and will initially serve approximately 100,000 customers worldwide.
Read more HERE